Performance funds/ETFs
Growth in fund currency
Available documents (NL)
Available documents (EN)
Available documents for this product 
Quote
Quote
€10,82
Quote date
01-04-2026
Performance in EUR
Date
01-04-2026
This year
-4,59%
1 week
1,27%
1 month
-6,17%
3 months
-4,59%
6 months
1,75%
1 year
-5,63%
3 years (annualised)
2,87%
5 years (annualised)
-
Since start (annualised)
2,18%
Indicators
Standard deviation (3yr)
13,00%
Share ratio (3yr)
0,05
Beta (3yr)
1,02
Alpha (3yr)
-0,60
Tracking error (3yr)
2,64
Top 10 holdings (30-03-2026)
Eli Lilly and Co
10,89 %
AbbVie Inc
7,20 %
Merck & Co Inc
5,07 %
AstraZeneca PLC
5,00 %
UnitedHealth Group Inc
4,55 %
Novartis AG Registered Shares
4,33 %
Roche Holding AG Ordinary Shares new
4,32 %
Amgen Inc
3,32 %
Thermo Fisher Scientific Inc
3,22 %
Gilead Sciences Inc
2,84 %
Fees
Entry fee
-->Tarievenkaart / Cost information sheet
Exit charges
-->Tarievenkaart / Cost information sheet
Estimated ongoing charges
0,18%
Dividend
Dividend paying
No
Characteristic
Asset Manager
Amundi
Asset class
Equities
Investment category
Equities - Healthcare
Active/Passive
Passive
Fund code
206360
Fund code fractional orders
-
Fund manager name
Quentin Berrou|Shan Zhao|Arnaud Vergonjeanne
ISIN
IE0006FM6MI8
Sustainable Classification
Art. 8, ESG integration
Sustainability Rating
Domicile
Ireland
Currency
EUR
Fund size (mio)
€481,71 (31-03-2026)
Cut-off time
-
Execution date
niet van toepassing: directe verhandeling op de beurs
Inception date
20-09-2022
Benchmark
S&P World Health Care Wghtd & Scr TR USD
Minimum investment amount
-
Assortiment
Self Directed Investing Plus, Investment advice